Immune-mediated processes have been implicated in the pathogenesis of diabetic polyneuropathy. Langerhans cells (LCs) are the sole dendritic cell type located in the healthy epidermis and exert tolerogenic immune functions. We aimed to determine whether alterations in cutaneous LC density and intraepidermal nerve fiber density (IENFD) are present in patients with recently diagnosed type 2 diabetes. Skin biopsy specimens from the distal leg from 96 type 2 diabetic patients and 75 healthy control subjects were used for quantification of LC density and IENFD. LCs and IENFs were labeled using immunohistochemistry. Nerve conduction studies, quantitative sensory testing, and neurological examination were used to assess peripheral nerve function. LC density was markedly reduced in the diabetic group compared with the control group, but did not correlate with reduced IENFD or peripheral nerve function. Multivariate linear regression analysis revealed a strong association between LC density and whole-body insulin sensitivity in women but not in men with diabetes. Prospective studies should establish whether the pronounced reduction of cutaneous LCs detected in recently diagnosed type 2 diabetes could promote a cutaneous immunogenic imbalance toward inflammation predisposing to polyneuropathy and foot ulcers. Recent evidence suggests the involvement of inflammatory processes in the pathogenesis of type 2 diabetes (T2D) (1) and its complications such as polyneuropathy (2). Diabetic neuropathy is associated with extensive morbidity, increased mortality, and reduced quality of life (3). A distal leg skin biopsy specimen with quantification of intraepidermal nerve fiber density (IENFD) is a reliable and efficient technique to assess the diagnosis of small fiber neuropathy (SFN) (4). However, the pathophysiological processes triggering the loss of IENFs in diabetic neuropathy are unknown. Langerhans cells (LCs) are the sole dendritic cells located in the healthy epidermis. IENFs have been shown to have an immune-modulatory effect on LCs (5). This finding indicates a close relationship between the nervous system and the function of distinct immune system components. In patients with type 1 diabetes, cutaneous LC density was markedly reduced immediately at diabetes
RESEARCH DESIGN AND METHODS
SubjectsThe study was conducted in accordance with the Declaration of Helsinki and was approved by the ethics committee of the Heinrich Heine University, Düsseldorf. All participants provided a written informed consent. Healthy control subjects (n = 75) and patients with recently diagnosed T2D (n = 96) were studied. Subjects with T2D were participants of the prospective German Diabetes Study (GDS), which evaluates the long-term course of diabetes and its sequelae (9). Inclusion criteria for entry into the GDS were type 1 or type 2 diabetes, known diabetes duration #1 year, and 18-69 years of age. Exclusion criteria were secondary diabetes, pregnancy, severe diseases (cancer), psychiatric disorders, immunosuppressive therapy, limited cooper...